Review

January 5, 2023


Clinical practice guideline and real-life practice in hepatocellular carcinoma: A Korean perspective
Myung Ji Goh, Dong Hyun Sinn, Jong Man Kim, et al.
Clin Mol Hepatol. 2023;29(2):197-205.

Review

December 22, 2022


Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Chinese perspective
Diyang Xie, Jieyi Shi, Jian Zhou, et al.
Clin Mol Hepatol. 2023;29(2):206-216.

Review

December 28, 2022


Clinical practice guidelines and real-life practice on hepatocellular carcinoma: A the Hong Kong perspective
Rex Wan-Hin Hui, Lung-Yi Mak, Tan-To Cheung, et al.
Clin Mol Hepatol. 2023;29(2):217-229.

Review

January 30, 2023


Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Taiwan perspective
Tung-Hung Su, Chih-Horng Wu, Tsung-Hao Liu, et al.
Clin Mol Hepatol. 2023;29(2):230-241.

Review

March 20, 2023


Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Japanese perspective
Hironori Koga, Hideki Iwamoto, Hiroyuki Suzuki, et al.
Clin Mol Hepatol. 2023;29(2):242-251.

Review

March 10, 2023


Overview of Asian clinical practice guidelines for the management of hepatocellular carcinoma: An Asian perspective comparison
Yuri Cho, Bo Hyun Kim, Joong-Won Park
Clin Mol Hepatol. 2023;29(2):252-262.

Review

January 19, 2023


The role of different viral biomarkers on the management of chronic hepatitis B
Lung-Yi Mak, Rex Wan-Hin Hui, James Fung, et al.
Clin Mol Hepatol. 2023;29(2):263-276.

Review

January 30, 2023


Utility of combining PIVKA-II and AFP in the surveillance and monitoring of hepatocellular carcinoma in the Asia-Pacific region
Do Young Kim, Bao Nguyen Toan, Chee-Kiat Tan, et al.
Clin Mol Hepatol. 2023;29(2):277-292.

Review

February 1, 2023


Neuropilins as potential biomarkers in hepatocellular carcinoma: a systematic review of basic and clinical implications
Paula Fernández-Palanca, Tania Payo-Serafín, Carolina Méndez-Blanco, et al.
Clin Mol Hepatol. 2023;29(2):293-319.

Review

February 1, 2023


Chronic hepatitis B with concurrent metabolic dysfunction-associated fatty liver disease: Challenges and perspectives
Shang-Chin Huang, Chun-Jen Liu
Clin Mol Hepatol. 2023;29(2):320-331.

Original Article

November 21, 2022


Single-cell phenotypes of peripheral blood immune cells in early and late stages of non-alcoholic fatty liver disease
Kathryn Jane Waller, Hajar Saihi, Wenhao Li, et al.
Clin Mol Hepatol. 2023;29(2):417-432.

Original Article

January 4, 2023


Global burden of primary liver cancer and its association with underlying aetiologies, sociodemographic status, and sex differences from 1990–2019: A DALY-based analysis of the Global Burden of Disease 2019 study
Sungchul Choi, Beom Kyung Kim, Dong Keon Yon, et al.
Clin Mol Hepatol. 2023;29(2):433-452.

Original Article

February 1, 2023


Factors associated with unrecognized cirrhosis in patients with hepatocellular carcinoma
Yi-Te Lee, Mohammad A. Karim, Hye Chung Kum, et al.
Clin Mol Hepatol. 2023;29(2):453-464.

Original Article

February 20, 2023


Taurocholic acid promotes hepatic stellate cell activation via S1PR2/p38 MAPK/YAP signaling under cholestatic conditions
Jing Yang, Xujiao Tang, Zhu Liang, et al.
Clin Mol Hepatol. 2023;29(2):465-481.

Original Article

January 5, 2023


Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune-tolerant phase
Jeong-Ju Yoo, Soo Young Park, Ji Eun Moon, et al.
Clin Mol Hepatol. 2023;29(2):482-495.

Original Article

March 6, 2023


Next-generation sequencing analysis of hepatitis C virus resistance–associated substitutions in direct-acting antiviral failure in South Korea
Kyung-Ah Kim, Sejoon Lee, Hye Jung Park, et al.
Clin Mol Hepatol. 2023;29(2):496-509.


Articles in E-pub version are posted online ahead of regular printed publication.

Review
The Evolving Role of Lenvatinib at the New Era of First-Line HCC Treatment
Landon L. Chan, Stephen L. Chan
Received March 22, 2023  Accepted May 25, 2023  
View: 89   Download: 10
Letter to the Editor
Assessing the performance of ChatGPT: Comment
Amnuay Kleebayoon, Viroj Wiwanitkit
Received May 18, 2023  Accepted May 23, 2023  
View: 74   Download: 11
Is liver biopsy mandatory to identify immune-tolerant phase of chronic hepatitis B?
Joo Hyun Oh, Dong Hyun Sinn
Received April 4, 2023  Accepted April 5, 2023  
View: 81   Download: 5
Non-alcoholic fatty liver disease: Definition and subtypes: Is time to change the concept from liver disease to systemic disease?
Seul Ki Han, Soon Koo Baik, Moon Young Kim
Received April 25, 2023  Accepted May 15, 2023  
View: 120   Download: 11
Original Article
Treated Chronic Hepatitis B Is a Good Prognostic Factor of Diffuse Large B-Cell Lymphoma
Jeayeon Park, Sung Won Chung, Yun Bin Lee, Hyunjae Shin, Moon Haeng Hur, Heejin Cho, Min Kyung Park, Jeonghwan Youk, Ji Yun Lee, Jeong-Ok Lee, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, Tae Min Kim, Jeong-Hoon Lee
Received February 13, 2023  Accepted May 16, 2023  
View: 167   Download: 19
Core indicators related to the elimination of hepatitis B and C virus infection in South Korea: A nationwide study
Chang Hun Lee, Gwang Hyeon Choi, Hwa Young Choi, Sojung Han, Eun Sun Jang, Young Eun Chon, Young Chang, Kyung-Ah Kim, Do Young Kim, Hyung Joon Yim, Hye-Lin Kim, Sook-Hyang Jeong, In Hee Kim
Received March 16, 2023  Accepted May 12, 2023  
View: 120   Download: 14
HCC prediction model performance decrease with long-term antiviral therapy in chronic hepatitis B patients
Xiaoning Wu, Xiaoqian Xu, Jialing Zhou, YaMeng Sun, Huiguo Ding, Wen Xie, Guofeng Chen, Anlin Ma, HongXin Piao, Bingqiong Wang, Shuyan Chen, Tongtong Meng, Xiaojuan Ou, Hwai-I Yang, Jidong Jia, Yuanyuan Kong, Hong You
Received March 27, 2023  Accepted May 10, 2023  
View: 193   Download: 21
Letter to the Editor
The upper limit of normal for ALT in males according to AASLD guideline
Halil Haldun Emiroglu
Received March 30, 2023  Accepted April 7, 2023  
View: 113   Download: 1
Subtypes of non-alcoholic fatty liver disease in terms of cardiovascular disease and dementia risks
Seogsong Jeong, Yohwan Lim, Su Kyoung Lee, Hyun Wook Han
Received March 29, 2023  Accepted April 5, 2023  
View: 153   Download: 16
Original Article
Classification of microvascular invasion of hepatocellular carcinoma: correlation with prognosis and MR imaging
Yoon Jung Hwang, Jae Seok Bae, Youngeun Lee, Bo Yun Hur, Dong Ho Lee, Haeryoung Kim
Received January 29, 2023  Accepted May 6, 2023  
View: 214   Download: 24
Impact of fatty liver on long-term outcomes in chronic hepatitis B: a systematic review and matched analysis of individual patient data meta-analysis
Yu Jun Wong, Vy H. Nguyen, Hwai-I Yang, Jie Li, Michael Huan Le, Wan-Jung Wu, Nicole Xinrong Han, Khi Yung Fong, Elizebeth Chen, Connie Wong, Fajuan Rui, Xiaoming Xu, Qi Xue, Xin Yu Hu, Wei Qiang Leow, George Boon-Bee Goh, Ramsey Cheung, Grace Wong, Vincent Wai-Sun Wong, Ming-Whei Yu, Mindie H. Nguyen
Received January 5, 2023  Accepted April 29, 2023  
View: 397   Download: 41
Review
KASL Clinical Practice Guidelines for Management of Autoimmune Hepatitis 2022
Received March 1, 2023  Accepted April 3, 2023  
View: 194   Download: 39
Hepatorenal Syndrome: Current Concepts and Future Perspectives
Chan-Young Jung, Jai Won Chang
Received January 25, 2023  Accepted April 10, 2023  
View: 1826   Download: 711
Original Article
Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Yee Hui Yeo, Jamil S. Samaan, Wee Han Ng, Peng-Sheng Ting, Hirsh Trivedi, Aarshi Vipani, Walid Ayoub, Ju Dong Yang, Omer Liran, Brennan Spiegel, Alexander Kuo
Received March 3, 2023  Accepted March 21, 2023  
View: 4668   Download: 758  Citations: 3
Review
Acute -on- Chronic liver failure – Terminology, Mechanisms and Management
Vinay Kumar BR, Shiv Kumar Sarin
Received April 16, 2022  Accepted February 25, 2023  
View: 864   Download: 224
Safety Considerations for Withdrawal of Nucleos(t)ide Analogues in Patients with Chronic Hepatitis B: First, Do No Harm
Yao-Chun Hsu, Cheng-Hao Tseng, Jia-Horng Kao
Received November 26, 2022  Accepted March 13, 2023  
View: 457   Download: 51
Hepatitis B core-related antigen: a novel and promising surrogate biomarker to guide anti-HBV therapy
Takako Inoue, Takehisa Watanabe, Yasuhito Tanaka
Received December 2, 2022  Accepted March 7, 2023  
View: 569   Download: 104  Citation: 1
Original Article
Comparison of glucagon-like peptide-1 receptor agonists and thiazolidinediones on treating nonalcoholic fatty liver disease: A network meta-analysis
Min Jeong Park, Hayeon Kim, Myeong Gyu Kim, Kyungim Kim
Received October 22, 2022  Accepted March 6, 2023  
View: 461   Download: 45
Review
A decade of liver organoids: Advancements in disease modeling
Yue Liu, Jian-Ying Sheng, Junjun Ding, Yun-Shen Chan
Received November 29, 2022  Accepted February 28, 2023  
View: 3169   Download: 114
Acute hepatitis C virus infection: clinical update and remaining challenges
Chen-Hua Liu, Jia-Horng Kao
Received October 30, 2022  Accepted February 16, 2023  
View: 767   Download: 174  Citations: 2
Development of hepatocellular carcinoma in treated and untreated patients with chronic hepatitis B virus infection
Chih-Lin Lin, Jia-Horng Kao
Received October 31, 2022  Accepted February 12, 2023  
DOI: https://doi.org/10.3350/cmh.2022.0342    [Epub ahead of print]
View: 691   Download: 132
Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma in the era of chemo-diversity
Hideki Iwamoto, Shigeo Shimose, Tomotake Shirono, Takashi Niizeki, Takumi Kawaguchi
Received November 9, 2022  Accepted February 9, 2023  
DOI: https://doi.org/10.3350/cmh.2022.0391    [Epub ahead of print]
View: 710   Download: 141  Citations: 2

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X

  • PubMed Central
  • PubMed
  • Scopus
  • KoreaMed
  • KoMCI
  • ScienceCentral
  • DOAJ
  • GoogleScholar
  • Similarity Check
  • Crossref Cited-by Linking
  • CrossMark
  • Funder Registry
  • Metadata
  • ORCID
  • MeSH on Demand
  • COPE
  • EMBASE
  • KOFST
  • ICMJE
  • Web of SCIENCE
Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 318
TOTAL : 1294752
Close layer